Dr. Catherine S. Diefenbach discusses clinical trials supported by the ECOG-ACRIN cooperative group.
Photo: NYU Langone Staff
Since 2007, NYU Langone Health’s Perlmutter 鶹Ƶapp Center has been a member of ECOG-ACRIN—formed by the merger of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network—a multidisciplinary, membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer.
Catherine S. Diefenbach, MD, an associate professor in the and director of the Clinical Lymphoma Program at Perlmutter 鶹Ƶapp Center, serves on ECOG-ACRIN’s Principal Investigator Committee. Dr. Diefenbach contributes a blog post describing some of the conducted at Perlmutter 鶹Ƶapp Center that are supported by ECOG-ACRIN.
“Perlmutter 鶹Ƶapp Center has a diverse portfolio of clinical trials that provides patients with access to the newest, most innovative therapies to treat their cancer,” Dr. Diefenbach writes.
Read more from the .
